Navigation Links
Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
Date:5/30/2012

LOS ANGELES, May 30, 2012 /PRNewswire/ -- Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS™) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.  The trial is being conducted at UCLA and is funded by NeuroSigma.  Mean decreases in PTSD measures of 36% and depression measures of over 50% were reported.

The study was conducted over an 8-week period and followed similarly designed eTNS trials conducted at UCLA, in which promising results were generated in treating both major depression and epilepsy.  Subjects had a mean age of 54 with a median of 28 years since traumatic exposure and suffered from both PTSD and MDD.  Current episodes were required to be of at least four months in duration, with non-response to at least one antidepressant.  In this outpatient trial, subjects placed stimulating eTNS electrodes on their foreheads for approximately eight hours each night while asleep, and the severity of PTSD and depression symptoms was measured every two weeks using standard recognized rating scales. 

"These findings are very encouraging," said Dr. Cook.  "The combination of depression and an anxiety disorder, like PTSD, is usually difficult to treat effectively.  The participants in the study told us that eTNS was easy to use at home and led, in some instances, to the best mental health they had experienced in years.  We expect these results, along with results from the remaining subjects in this Phase I trial, to form the basis for an upcoming Phase II clinical trial
'/>"/>

SOURCE NeuroSigma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
2. Codexis Appoints Interim Chief Executive Officer
3. Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
4. Quark Pharmaceuticals Reports Favorable Interim Results from Phase I Clinical Study of QPI-1007 in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
5. Breast Cancer Vaccine Reduces Cancer Recurrence in Women: Interim Results From Phase 2 Clinical Trial Trend Toward AE37 Vaccine Benefit; Results Presented at SABCS
6. Golden Meditech FY2011-12 Interim Results
7. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
8. Interim Data Announced for BIBF 1120 as Compared to bevacizumab in Combination Chemotherapy in Metastatic Colorectal Cancer
9. Dr. Eva Feldman, Principal Investigator, Presents Interim Data on Neuralstem ALS Trial
10. Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
11. Landauer Elects Board Member Michael T. Leatherman as Interim Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Ga. , July 6, 2015  EndoChoice Holdings, ... its second quarter 2015 financial results on Thursday, August ... EndoChoice will hold a conference call on Thursday, August ... results. The dial-in numbers are (866) 807-9684 for domestic ... webcast of the conference call will be available on ...
(Date:7/6/2015)... July 6, 2015  Nitin Tandon, M.D., UTHealth ... Memorial Hermann Mischer Neuroscience Institute at ... RNS® System technology into the skull of a ... of seizures – the first time this procedure ... "Epilepsy is a neurological condition that affects ...
(Date:7/6/2015)... 6, 2015 Mauna Kea ... multidisciplinary confocal laser endomicroscopy platform, announced today it ... Ministry of Health, Labor and Welfare (MHLW) ... the AQ-Flex 19 miniprobe.   Used ... miniprobe is comprised of a fiber-optic microscope that ...
Breaking Medicine Technology:EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 3Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 4Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3
... REDWOOD CITY, Calif., Feb. 6, 2012 Cardica, Inc. (Nasdaq: ... fiscal second quarter ended December 31, 2011. Cardica,s management will ... to discuss the financial results and provide an update on ... progress on bringing our MicroCutter product line to the marketplace," ...
... 2012  A recent discovery by Van Andel Research Institute ... proposed drug therapies for glioblastoma – the most common ... The study, published in January in the ... , investigated glioblastoma models characterized by cell signaling activation ...
Cached Medicine Technology:Cardica Announces Fiscal 2012 Second Quarter Financial Results 2Cardica Announces Fiscal 2012 Second Quarter Financial Results 3Cardica Announces Fiscal 2012 Second Quarter Financial Results 4Cardica Announces Fiscal 2012 Second Quarter Financial Results 5Cardica Announces Fiscal 2012 Second Quarter Financial Results 6Discovery Predicts Patient Sensitivity to Important Drug Target in Deadly Brain Cancer 2
(Date:7/7/2015)... ... July 07, 2015 , ... On May 29, 2015, ... and permits the use of gluten-free claims for gluten free oats and foods that ... the Gluten-Free Certification Program (GFCP) to include gluten-free oat products in Canada,” ...
(Date:7/7/2015)... ... 2015 , ... Each year the Holiday Inn Westbury donates many ... and international level; however, the Holiday Inn now hosts one large event at the ... the beneficiaries. In September of 2014 they hosted an event with all proceeds going ...
(Date:7/6/2015)... Laguna Woods, CA (PRWEB) , ... July 06, ... ... first Water Revival System that eliminates 100% of all acids, chemicals and impurities; ... not suggested for drinking water because it contains harmful contaminants.  These harmful contaminants ...
(Date:7/6/2015)... ... ... Shortly after opening her second practice in Signal Hill, Dr. Sue Lim ... lien basis. Dr. Lim had previously worked with Dr. Kevin Kelly, DC a ... Lim suffered with back pain herself throughout high school. Unaware of the benefits ...
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is proud ... Post Graduate Teaching Award on behalf of the department of Family Practice. , “This ... field to be practicing in. The technology is changing so rapidly and we are ...
Breaking Medicine News(10 mins):Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 2Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 3Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2
... When children with asthma get the flu, they often land ... Boston have found a previously unknown biological pathway explaining why ... online May 29 by the journal Nature Immunology , ... cells called natural helper cells presenting a completely new ...
... 27 (HealthDay News) -- Contrary to the belief of ... violence doesn,t make kids enjoy them more, a new ... of children,s TV shows now contain some degree of ... watching animated shows identified more with non-violent characters. ...
... University of British Columbia,s Faculties of Medicine, Science ... trial aimed at improving outcomes for patients undergoing ... by the Terry Fox Research Institute, the Canadian ... or COOLS Study, involves universities and hospitals in ...
... the connection between vitamin D and multiple sclerosis in African ... San Francisco has discovered that vitamin D levels in the ... compared to African Americans who do not. "It seems ... of the UCSF Multiple Sclerosis Center, director of the UCSF ...
... -- People with rheumatoid arthritis are twice as likely ... (COPD), a large new study finds. The ... disorder was evident even when factors such as smoking, ... Israeli researchers. The study was to be presented Thursday ...
... the creation of two Franco-German joint research laboratories to promote ... a new form of cooperation in life sciences and health ... will be set up for an initial period of five ... cofinanced by the two institutions, will be located in France, ...
Cached Medicine News:Health News:Why does flu trigger asthma? 2Health News:Violence Doesn't Make TV Shows More Enjoyable for Kids 2Health News:UBC researchers to lead $4.7-million study on early-stage oral cancer 2Health News:Low vitamin D levels seen as multiple sclerosis risk for African-Americans, UCSF study finds 2Health News:Low vitamin D levels seen as multiple sclerosis risk for African-Americans, UCSF study finds 3Health News:Rheumatoid Arthritis May Double Risk of COPD 2Health News:The Helmholtz Association and Inserm create 2 joint research laboratories in France 2Health News:The Helmholtz Association and Inserm create 2 joint research laboratories in France 3
Wire mesh braided design with a platinum core....
... Finnpipette Focus multichannel pipettes ... of reagents into microplates, ... 0.1-10 l volumes. The ... Finnpipette Focus multichannels, combined ...
... The Finnpipette Digital Multichannel, ... even lighter work of routine ... all these advanced features: Soft-touch ... micro volume pipetting (0.5-10ul models), ...
... and Benefits: 1-12channel pipette This ... product number, created to easily ... showing no availability yet, please ... number (Z37,173-4) or contact customer ...
Medicine Products: